2-styryl-pyridines and 2-(3,4-dihydro-naphthalen-2-yl)-pyridines as potent NR1/2B subtype selective NMDA receptor antagonists

被引:4
作者
Buettelmann, B [1 ]
Alanine, A
Bourson, A
Gill, R
Heitz, MP
Mutel, V
Pinard, E
Trube, G
Wyler, R
机构
[1] F Hoffmann La Roche Ltd, Div Pharma, Discovery Chem, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Div Pharma, Preclin CNS Res, CH-4070 Basel, Switzerland
关键词
neurodegeneration; NMDA; NR1/2B antagonists; structure-activity relationship;
D O I
10.2533/000942904777677579
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of 2-styryl-pyridines and 2-(3,4-dihydro-naphthalen-2-yl)-pyridines was prepared and evaluated as NR1/2B subtype selective NMDA receptor antagonists. The SAR developed in this series resulted in the discovery of high affinity antagonists that are selective (vs. alpha(1) and M-1 receptors) and are active in vivo.
引用
收藏
页码:630 / 633
页数:4
相关论文
共 22 条
[21]  
WILLIAMS K, 1993, MOL PHARMACOL, V44, P851
[22]   Discovery of subtype-selective nmda receptor ligands: 4-benzyl-1-piperidinyalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists [J].
Wright, JL ;
Gregory, TF ;
Boxer, PA ;
Meltzer, LT ;
Serpa, KA ;
Wise, LD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (19) :2815-2818